The effect of rate of weight loss on long-term weight management: a randomised controlled trial
Share honestly and often
Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease: results from the LEADER trial
If you're taking insulin, sulfonylureas, or other diabetes medications alongside GLP-1 therapy, you're at higher risk for hypoglycemia
When GLP-1 receptor agonists slow your gastric emptying, they change the entire rhythm of your digestive system, from stomach to colon
if more than 3 days, skip that dose Daily GLP-1s: If you miss a dose, follow your PIL instructions If you take insulin or sulfonylureas alongside GLP-1 medications, do not adjust these doses yourself without medical advice, as this could increase hypoglycaemia risk Report persistent side effects to your GP rather than stopping treatment abruptly Some patients may require dose adjustment if they develop acute illness, undergo surgery, or experience significant changes in kidney function